Vizgen IPO

vizgen.com

Vizgen, founded in 2019, is dedicated to pioneering the next generation of genomics, providing tools that demonstrate the possibilities of in situ single cell spatial genomics, setting the standard for the spatial genomics field. These tools are enabling researchers to gain new insight into the biological systems that govern human health and disease with spatial context. The company's MERSCOPE Platform enables massively multiplexed, genome-scale nucleic acid imaging with high accuracy and unrivaled detection efficiency at subcellular resolution.

Founded2019
Total Funding to Date$136.2MM
Register for Details

For more details on financing and valuation for Vizgen, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Vizgen Ticker Symbol

Vizgen does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Vizgen Stock Price

The stock price for Vizgen will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Vizgen Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
6/3/2022 Series C $85.2MM raised $XXX.XX $XXX.XX
4/7/2021 Series B $37MM raised $XXX.XX $XXX.XX
1/30/2020 Series A $14MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Vizgen in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector